HEALTH TECHNOLOGY

Viveon Health Acquisition Corp. Announces Filing of Registration Statement on Form S-4 in Connection with Suneva Medical

Viveon Health Acquisition Corp. | July 16, 2022 | Read time : 1 min

Viveon Health

Viveon Health Acquisition Corp. a special purpose acquisition company, and Suneva Medical, Inc. an innovative medical technology company using regenerative medicine to change the standard of care in aesthetic treatments, announced that VHAQ filed a registration statement on Form S-4 with the U.S. Securities and Exchange Commission on July 13, 2022.

The Registration Statement, contains a preliminary proxy statement/prospectus in connection with the previously announced business combination between VHAQ and Suneva. While the information within the Registration Statement is subject to change, it provides important information about Suneva Medical and VHAQ, as well as the proposed business combination.

On January 12, 2022, VHAQ entered into a merger agreement with Suneva. The combined company is expected to be listed on the NYSE American upon completion of the transaction, which is expected to occur in the second half of 2022, subject to approval by VHAQ’s shareholders, the Registration Statement being declared effective by the SEC, and other customary closing conditions.

Included in the Registration Statement are Suneva’s financial results for 2021 and for the first quarter of 2022. Overall, Suneva delivered strong revenue growth in 2021 and generated $29.5 million of net sales and $6.3 million in Q1 of 2022. Suneva’s full financial results and related disclosures can be found in the Registration Statement.

About Suneva Medical, Inc.
Suneva Medical, Inc., headquartered in San Diego, CA, is a leader in regenerative aesthetics. It is focused on developing, manufacturing and commercializing branded products for providers and their patients. Suneva offers a portfolio of products to address the impact of the aging process to deliver solutions that leverage the body’s own restorative capacity. The product portfolio is composed of several “only” and “first to market” solutions with both FDA PMA approval and 510(k) clearance. 

About Viveon Health Acquisition Corp.
Viveon Health Acquisition Corp. is a blank check company, also commonly referred to as a special purpose acquisition company, or SPAC, formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.
 

Spotlight

Today, it would be difficult to find medical device technology that does not critically depend on computer software. Network connectivity and wireless communication has transformed the delivery of patient care. The technology often enables patients to lead more normal and healthy lives. However, medical devices that rely on software (e.g., drug infusion pumps, linear accelerators, pacemakers) also inherit the pesky cybersecurity risks endemic to computing.

Spotlight

Today, it would be difficult to find medical device technology that does not critically depend on computer software. Network connectivity and wireless communication has transformed the delivery of patient care. The technology often enables patients to lead more normal and healthy lives. However, medical devices that rely on software (e.g., drug infusion pumps, linear accelerators, pacemakers) also inherit the pesky cybersecurity risks endemic to computing.

Related News

HEALTH TECHNOLOGY

MobileSmith Health Announces Go-Live at CHI St. Vincent Infirmary

MobileSmith | September 15, 2022

MobileSmith a leading provider of cutting-edge mobile software solutions, announces delivery and live status of their PeriOp solution at CHI St. Vincent Infirmary. MobileSmith Health is proud to partner with CHI St. Vincent in improving throughput and clinical care for surgical patients using the PeriOp solution. This toolset provides visibility of patient activities and status to the clinical team preparing to welcome patients for surgery. The adherence dashboard helps clinicians focus on the patients who need the most help. Patients, in turn, get education about their procedure, complete necessary preoperative tasks, and are better prepared to manage their care at home. "We are thrilled to partner with CHI St. Vincent and their innovative team. Our work addresses patient outcomes while improving patient satisfaction. It also reduces the workload of clinical staff by automating routine tasks and improving predictability in patient throughput," Chris Caramanico, Chief Executive Officer of MobileSmith Health "The MobileSmith Health team has been a pleasure to work with. We have a shared vision and passion to make healthcare communication to the patient reliable and more efficient. The combination of MobileSmith Health and our talented and innovative team at CHI St. Vincent are proving that we can make a difference in the daily work of many clinicians while improving patient outcomes," said Dr. Jill Flaxman, Medical Director of Perioperative Services. About MobileSmith MobileSmith Health is a digital health technology company focused on increasing efficiency and improving outcomes by providing clinicians with modern pre- and post-surgery dashboard, showing how patients participate in their own care. PeriOp, MobileSmith Health’s patient app, connects providers to their patients, streamlines information, simplifies surgery preparation and discharge and reduces complications. PeriOp by MobileSmith Health makes the science, process and oversight simple.

Read More

FUTURE OF HEALTHCARE

Brain Navi Biotechnology Announced Partnership with Distributor, Medtreq Medical Equipment

Brain Navi Biotechnology Co., Ltd. | September 12, 2022

Brain Navi, the leading surgical robot manufacture in Taiwan, announced a strategic partnership with distributor, Medtreq Medical Equipment, to expand the distribution of the Surgical Navigation Robot, NaoTrac, throughout the region of GCC region, Jordan, Egypt plus other countries in the Middle East and Philippines, Indonesia, Malaysia, and Singapore which will be covered by Medtreq branch in Philippines. NaoTrac, a CE-certified and local government approval neurosurgical navigation robot from Brain Navi Biotechnology, is embedding dissimilar technology named SMART Technology which combining the machine vision and in-house algorithm to perform robot-assisted surgery, to streamline surgical procedures with real-time imaging and minimal invasive outcomes. "We are always scouting for the new technology to help as many people as we can. We have many neurosurgeons coming from Riyadh and some other territories keening and willing to learn more about this technology, and the NaoTrac from Brain Navi is one of them. We are always happy to partner with an innovative technology company," Sherif Bayoumy, the General Manager of Medtreq Medical Equipment The collaboration and partnership between Brain Navi and Medtreq enables greater innovative outcome in the Middle East neurosurgery, such as Saudi Arabia, UAE, Egypt, Jordan, and some of the other countries on progressing, to streamline the surgical procedure, improve the surgical accuracy and pass-on knowledge to shorten the learning curves. "We seek strategic partners that can accelerate Brain Navi's growth mission. This partnership is a significant step toward scaling our business and getting more robot-assisted neurosurgery into the world," said Jerry Chen, the CEO of Brian Navi Biotechnology. "The collaboration between Metreq and Brain Navi is looking positive because we share the same mission to innovate with technology to make the life bright. We truly believe that the collaboration between Brain Navi and Medtreq can maximum the value of both sides to bring the neurosurgery to the next level." About Metreq Medical Equipment Bahrain Medtreq Medical Equipment provides professional technical support and after-service to clients in the MENA region with a presence in Bahrain and GCC, Egypt, North Africa, Turkey, Europe, the United States (Medtreq Tenessee USA), and the Philippines, Singapore, Malaysia, and Indonesia. Medtreq is built on high values, principles, and social commitment to society and humanity. About Brain Navi Brain Navi Biotechnology is a leading Taiwanese surgical robotic company. We design and develop innovative navigation and robotic surgery technologies for surgeons to improve surgical accuracy. Brain Navi's exclusive Surface Mapping Auto-registration Technology (SMART) is a significant surgical robotic breakthrough that merges machine vision, robotics, and AI technology to achieve streamlined surgical procedures with real-time imaging and minimal invasive outcomes.

Read More

HEALTH TECHNOLOGY

Gradient AI Acquires Healthcare Analytics Business Unit from Prognos Health to Expand Medical Underwriting Offering

Gradient AI and Prognos Health | October 11, 2022

Self Insurance Institute of America conference -October 10, 2022- Gradient AI, a leading enterprise software provider of artificial intelligence (AI) solutions in the insurance industry announced that it has acquired Prognos Health’s analytics business underwriting unit to leverage data from the company’s large collection of integrated medical records and lab data via its real-world data marketplace. The acquisition will enable Gradient AI to expand its medical database capabilities by integrating Prognos Health’s data with SAIL™, Gradient AI’s leading medical underwriting solution. Medical records on 325 million de-identified U.S. patients can be accessed through the Prognos Marketplace. In addition to retrieving medical and prescription claims data customers will now have access to lab data, which has been a missing factor for many insurers when predicting group risk. According to the Centers for Disease Control and Prevention (CDC), 70% of today’s medical decisions depend on laboratory test results because they are among the best indicators of disease severity and progression. With the acquisition, Gradient AI will become the only company in the group medical insurance market to provide medical, prescription, and lab data from a single source. Insurers will benefit by having further insight into group members' health for more informed risk assessment and improved underwriting accuracy. “The acquisition of Prognos underwriting business unit is a game changer. Our combined solution will provide a holistic picture of group health risk that has never before been possible. Insurers will now have a single point of access to multiple data sources, covering medical, prescription and lab data improving their abilities to project group health assessments and costs with much greater confidence.” Stan Smith, CEO and founder, Gradient AI Gradient AI aspires to continue its innovation in assessing group health risks. In the future, the company plans to expand its data sources to include information from Electronic Health Records and claims-based patient population data. “We are excited to join forces with Gradient AI to create a next-generation industry leading solution for group health insurance,” said Sundeep Bhan, co-founder and CEO, Prognos Health. “Gradient AI is a clear leader in healthcare analytics underwriting. Prognos looks forward to supporting the rapid innovation at Gradient AI by leveraging the most relevant data from the Prognos Marketplace. With the sale of the underwriting business unit, Prognos will continue to focus on our real-word data marketplace and democratizing data to improve health.” About Prognos Health Prognos Health’s mission is to democratize data to improve health. Prognos is focused on enabling data accessibility for everyone by leveraging technology and our clinical experience. We are removing data silos and fragmentation by linking, normalizing and standardizing data. We allow data to flow more freely and help organizations make the best data-informed decisions by simplifying and streamlining access to fit-for-purpose, multi-dimensional real-world data sets. Prognos is the leading real-world data marketplace with integrated RWD on 325M patients. All data purchased is available on the Datavant token, making it interoperable with other patient-level data that has been tokenized using Datavant. About Gradient AI Gradient AI is a leading provider of proven artificial intelligence (AI) solutions for the insurance industry. Its solutions improve loss ratios and profitability by predicting underwriting and claim risks with greater accuracy, as well as reducing quote turnaround times and claim expenses through intelligent automation. Unlike other solutions that use a limited claims and underwriting dataset, Gradient's software-as-a-service (SaaS) platform leverages a vast dataset comprised of tens of millions of policies and claims. It also incorporates numerous other features including economic, health, geographic and demographic information. Customers include some of the most recognized insurance carriers, MGAs, TPAs, risk pools, PEOs and large self-insureds across all major lines of insurance. By using Gradient AI’s solutions, insurers of all types achieve a better return on risk.

Read More